FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2019/01/017047 [Registered on: 11/01/2019] Trial Registered Prospectively
Last Modified On: 09/01/2019
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Comparative study on effect of alkaline preparation of two species of chiraita processed in Buffalo urine in loss of digestive power.  
Scientific Title of Study   Comparative clinical study on kshar of Swertia chirayata roxb. Flem. and Swertia angustifolia buch-ham.Exd.Don,processed in mahish mootra w.s.r.to agnideepan activity.  
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Mohan lal Jaiswal  
Designation  Professor  
Affiliation  National Institute of Ayurveda  
Address  Department of Dravyaguna, National Institute of Ayurveda, Jorawar Singh Gate, Amer road, Jaipur, Rajasthan.

Jaipur
RAJASTHAN
302002
India 
Phone  9414778431  
Fax    
Email  polospirit2018@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Sabita Sapkota  
Designation  PG scholar  
Affiliation  National Institute of Ayurveda  
Address  Department of Dravyaguna, National Institute of Ayurveda, Jorawar Singh Gate, Amer road, Jaipur

Jaipur
RAJASTHAN
302002
India 
Phone  09587112737  
Fax    
Email  sapkotasabita1988@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Sabita Sapkota  
Designation  PG scholar  
Affiliation  National Institute of Ayurveda  
Address  Department of Dravyaguna, National Institute of Ayurveda, Jorawar Singh Gate, Amer road, Jaipur, Rajasthan

Jaipur
RAJASTHAN
302002
India 
Phone  09587112737  
Fax    
Email  sapkotasabita1988@gmail.com  
 
Source of Monetary or Material Support  
National Institute of Ayurveda,Jorawar Singh Gate,Amer Road,Jaipur,Rajasthan,302002 
 
Primary Sponsor  
Name  National Institute of Ayurveda  
Address  Jorawar Singh gate, Amer road, Jaipur, Rajasthan  
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Sabita Sapkota   National Institute of Ayurveda  Room no-19,Department of Dravyaguna
Jaipur
RAJASTHAN 
9587112737

sapkotasabita1988@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
IEC, National Institute of Ayurveda   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: K929||Disease of digestive system, unspecified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Kshar of Swertia angustifolia .   Kshar of Swertia angustifolia 1gm/day in two divided doses will be given orally for 21 days with 3gm melted ghee.  
Comparator Agent  Kshar of Swertia chirayata.   Kshar of Swertia chirayata 1gm/day in two divided doses will be given orally for 21 days with 3gm melted ghee.  
 
Inclusion Criteria  
Age From  20.00 Year(s)
Age To  70.00 Year(s)
Gender  Both 
Details  1.Patients having classical signs and symptoms of jatharagnimandhya like Avipaka, Chardi, Angamard, Udara Gaurav, Ksudhanasa, Mukha durgandha, etc will be selected.
2.Patients of either sex with age group between 20 to 70 years will be selected.  
 
ExclusionCriteria 
Details  Patients with chronic disease like severe Hypertension, IHD, COPD, DM, cancer, Hepatic and renal insufficiency, psychotic disorders like depression, schizophrenia.
2.Any acute illness /serious illness.
3.Pregnant women and lactating mothers.  
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   An Open list of random numbers 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Improvement in subjective and objective parameters.   21days 
 
Secondary Outcome  
Outcome  TimePoints 
To find comparative efficacy of either treatment.   21 days  
 
Target Sample Size   Total Sample Size="40"
Sample Size from India="40" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3 
Date of First Enrollment (India)   15/01/2019 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="0"
Days="21" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   None yet 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary   Ayurveda views the health of an individual as the proper functioning of Agni(digestive fire inside body). Agnimandhya is the pathological state of inhibited agni.As per Acharya Baghbhat Agnimandhya leads to manifestation of all types of diseases. Kshar is prescribed to cure Agnimandhya . Acharya Charak has described Bhunimbadi kshar to cure Agnimandhya. In this study kshar of two species of chiraita (bhunimb) i. e Swertia chirayata and Swertia angustifolia  are taken. The study aims to compare the effectiveness of both drugs.  
Close